Cargando…

Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic

OBJECTIVE: To evaluate whether rates of healthcare-associated infections (HAIs) changed during the coronavirus disease 2019 (COVID-19) pandemic in malignant hematology and stem cell transplant patients. DESIGN: A retrospective, cohort study. PATIENTS: The study included malignant hematology and stem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobbitt, Laura J., Satyanarayana, Gowri, Van Metre Baum, Laura, Nebhan, Caroline A., Kassim, Adetola A., Gatwood, Katie S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615006/ https://www.ncbi.nlm.nih.gov/pubmed/36310802 http://dx.doi.org/10.1017/ash.2021.237

Ejemplares similares

Development and implementation of “handshake rounds”: An antibiotic stewardship intervention for hospitalized adult patients with hematologic malignancies
por: Gorsline, Chelsea A., et al.
Publicado: (2023)

HEALTHCARE UTILIZATION IN OLDER ADULTS (≥70 YEARS) UNDERGOING CELLULAR THERAPY FOR HEMATOLOGIC MALIGNANCIES
por: Snider, Christina, et al.
Publicado: (2022)

SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
por: Ni, Bin, et al.
Publicado: (2022)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
por: Mangan, Brendan L., et al.
Publicado: (2020)

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy
por: Kassim, Adetola A., et al.
Publicado: (2022)

2019–2020 Drug Updates in Hematologic Malignancies
por: Finnes, Heidi D.
Publicado: (2021)

2018–2019 Drug Updates in Hematologic Malignancies
por: Held, Lauren
Publicado: (2020)

The Essentials of Drug Interactions in Hematopoietic Stem Cell Transplantation
por: Gatwood, Katie S., et al.
Publicado: (2019)

Discordance Between Radiologic Findings and Molecular Testing in Patients With Underlying Hematologic Malignancy and Coronavirus Disease 2019
por: Raja, Mohammed, et al.
Publicado: (2020)

The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients
por: Hakki, Morgan, et al.
Publicado: (2015)

Molecular Testing in Hematologic Malignancies
por: Zitella, Laura J.
Publicado: (2022)

Hematological findings in coronavirus disease 2019: indications of progression of disease
por: Liu, Xiaoqing, et al.
Publicado: (2020)

Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab
por: Hall, Victoria G, et al.
Publicado: (2023)

Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies
por: Ogimi, Chikara, et al.
Publicado: (2017)

The effects of N95 mask and face shield on speech perception among healthcare workers in the coronavirus disease 2019 pandemic scenario
por: Bandaru, S V, et al.
Publicado: (2020)

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
por: Fabricius, William A., et al.
Publicado: (2016)

Unmanipulated haploidentical transplantation for adult patients with hematological malignancies
por: Ruggeri, Annalisa, et al.
Publicado: (2019)

Lung Transplantation for Coronavirus Disease-2019 Patients and Coronavirus Disease-2019 in Lung Transplant Recipients
por: Avella, Diego, et al.
Publicado: (2023)

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation
por: Yuda, Sayako, et al.
Publicado: (2022)

Hematology profile analysis in coronavirus disease 2019 (COVID-19) patients
por: Setio, Felisia, et al.
Publicado: (2022)

Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
por: Agha, Mounzer E, et al.
Publicado: (2021)

Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update
por: Patel, Dilan A., et al.
Publicado: (2020)

Role of Notch Receptors in Hematologic Malignancies
por: Gragnani, Laura, et al.
Publicado: (2020)

Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology
por: Khawaja, Fareed, et al.
Publicado: (2023)

Coronavirus disease 2019 and transplantation: A view from the inside
por: Gori, Andrea, et al.
Publicado: (2020)

Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplantation Recipients and Hematologic Malignancy Patients
por: Ogimi, Chikara, et al.
Publicado: (2016)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Hematologic Malignancies
Publicado: (2019)

Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy
por: Linder, Kathleen A, et al.
Publicado: (2019)

Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
por: Dashputre, Ankur A., et al.
Publicado: (2020)

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
por: Mahmoud, Hossam K., et al.
Publicado: (2015)

Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies
por: Green, Margaret L.
Publicado: (2017)

Coronavirus disease 2019 and renal transplantation
por: Nassar, Mahmoud, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
por: Słomka, Artur, et al.
Publicado: (2020)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

The DNA methylation landscape of hematological malignancies: an update
por: Blecua, Pedro, et al.
Publicado: (2020)

Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
por: Dillon, Hayley T., et al.
Publicado: (2022)

Reinfection or Reactivation of Coronavirus-19 in Patients with Hematologic Malignancies: Case Report Series
por: Kapoor, Rajan, et al.
Publicado: (2021)

Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance
por: Maia, Catarina, et al.
Publicado: (2020)

Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
por: Amonoo, Hermioni L., et al.
Publicado: (2022)

Clinical Usefulness of Bronchoalveolar Lavage in the Management of Pulmonary Infiltrates in Adults with Hematological Malignancies and Stem Cell Transplantation
por: Jorge, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_elp0pi8en8d5pl6ln82r7tbo23